Adcock Ingram Holdings Ltd. is a pharmaceutical company, which engages in the manufacture, marketing, and distribution of healthcare products to both private and public sectors of the market. The company is headquartered in Midrand, Gauteng. The company went IPO on 2008-08-25. The firm manufactures, markets, and distributes a range of healthcare and consumer products, and is a supplier to the private sector. Its segments include Consumer, Over the Counter (OTC), Prescription, Hospital, and Other. The Consumer segment is engaged mainly in the fast-moving consumer goods (FMCG) space. The OTC segment focuses on brands sold predominantly in pharmacies. The Prescription segment markets products prescribed by medical practitioners, and specialized instruments and surgical products. Its Hospital segment supplies hospital and critical care products, including intravenous solutions, blood collection products, and renal dialysis systems. The Other segment includes shared services and other support services, including regulatory services in India, as well as the investment in the joint venture and cash and bank overdraft balances, which are managed on a central basis in Southern Africa.
Follow-Up Questions
Adcock Ingram Holdings Ltd의 CEO는 누구입니까?
Mr. Andrew Hall은 2007부터 회사에 합류한 Adcock Ingram Holdings Ltd의 Chief Executive Officer입니다.
AIHLF 주식의 가격 성능은 어떻습니까?
AIHLF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Adcock Ingram Holdings Ltd의 주요 사업 주제나 업종은 무엇입니까?
Adcock Ingram Holdings Ltd은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
Adcock Ingram Holdings Ltd의 시가총액은 얼마입니까?
Adcock Ingram Holdings Ltd의 현재 시가총액은 $0입니다
Adcock Ingram Holdings Ltd는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 Adcock Ingram Holdings Ltd에 대한 분석 평가를 실시했으며, 이는 0명의 강력한 매수, 0명의 매수, 4명의 보유, 3명의 매도, 그리고 0명의 강력한 매도를 포함합니다